Company

Biosynex SA

Headquarters: Illkirch-Graffenstaden, France

Employees: 192

CEO: Mr. Larry Abensur

Market Cap

€90.2 Million

EUR as of Jan. 1, 2024

US$99.6 Million

Market Cap History

Biosynex SA market capitalization over time

Evolution of Biosynex SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Biosynex SA

Detailed Description

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also exports its products internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Biosynex SA has the following listings and related stock indices.


Stock: FSX: 0DL wb_incandescent

Stock: Euronext: ALBIO wb_incandescent

Stock: Euronext: BIOBS wb_incandescent

Details

Headquarters:

22 Boulevard Sébastien Brant

Illkirch-Graffenstaden, 67400

France

Phone: 33 3 88 77 57 00